Gene therapy firm Kriya Therapeutics snags $270m Series C
Kriya Therapeutics, Inc., a gene therapy company, has raised $270 million in Series C financing.
Kriya Therapeutics, Inc., a gene therapy company, has raised $270 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination